EKG vs. IDNA
EKG (First Trust Nasdaq Lux Digital Health Solutions ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - EKG tracks the NASDAQ Lux Health Tech Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 3 years, EKG returned -0.66%/yr vs 6.74%/yr for IDNA. A 0.67 correlation means they provide meaningful diversification when combined. EKG charges 0.65%/yr vs 0.47%/yr for IDNA.
Performance
EKG vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, EKG achieves a -10.11% return, which is significantly lower than IDNA's 10.31% return.
EKG
- 1D
- -0.20%
- 1M
- 2.98%
- YTD
- -10.11%
- 6M
- -12.99%
- 1Y
- -0.93%
- 3Y*
- -0.66%
- 5Y*
- —
- 10Y*
- —
IDNA
- 1D
- 0.73%
- 1M
- -2.56%
- YTD
- 10.31%
- 6M
- 8.52%
- 1Y
- 40.87%
- 3Y*
- 6.74%
- 5Y*
- -8.42%
- 10Y*
- —
EKG vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | -10.11% | 11.89% | 6.53% | -0.11% | -19.59% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 10.31% | 17.26% | -0.72% | -7.63% | -26.25% |
Correlation
The correlation between EKG and IDNA is 0.58, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.58 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.59 |
Correlation (All Time) Calculated using the full available price history since Mar 24, 2022 | 0.67 |
The correlation between EKG and IDNA has been stable across timeframes, ranging from 0.58 to 0.67 - a consistent structural relationship.
EKG vs. IDNA - Sectors Allocation Comparison
Sectors
EKG
IDNA
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
Real Estate
-
-
Utilities
-
-
Healthcare
EKG
IDNA
Technology
EKG
IDNA
-
Basic Materials
EKG
-
IDNA
-
Communication Services
EKG
-
IDNA
-
Consumer Cyclical
EKG
-
IDNA
-
Consumer Defensive
EKG
-
IDNA
-
Energy
EKG
-
IDNA
-
Financial Services
EKG
-
IDNA
-
Industrials
EKG
-
IDNA
Real Estate
EKG
-
IDNA
-
Utilities
EKG
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
EKG vs. IDNA — Risk / Return Rank
EKG
IDNA
EKG vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| EKG | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.72 | ||
| Sortino ratioReturn per unit of downside risk | -2.35 | ||
| Omega ratioGain probability vs. loss probability | 1.01 | 1.27 | -0.26 |
| Calmar ratioReturn relative to maximum drawdown | -0.04 | 3.85 | -3.89 |
| Martin ratioReturn relative to average drawdown | -0.10 | 10.98 | -11.07 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| EKG | IDNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.04 | 1.68 | -1.72 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | -0.30 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.13 | 0.10 | -0.23 |
Drawdowns
EKG vs. IDNA - Drawdown Comparison
The maximum EKG drawdown since its inception was -43.82%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for EKG and IDNA.
Loading charts...
Drawdown Indicators
| EKG | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.82% | -68.26% | +24.44% |
Max Drawdown (1Y)Largest decline over 1 year | -22.09% | -10.66% | -11.43% |
Max Drawdown (3Y)Largest decline over 3 years | -34.49% | -29.73% | -4.76% |
Max Drawdown (5Y)Largest decline over 5 years | — | -68.26% | — |
Current DrawdownCurrent decline from peak | -20.78% | -45.61% | +24.83% |
Average DrawdownAverage peak-to-trough decline | -22.66% | -36.24% | +13.58% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 9.73% | 3.73% | +6.00% |
Volatility
EKG vs. IDNA - Volatility Comparison
First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) have volatilities of 7.09% and 7.18%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| EKG | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.09% | 7.18% | -0.09% |
Volatility (6M)Calculated over the trailing 6-month period | 16.42% | 17.98% | -1.56% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.57% | 24.48% | -2.91% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 27.07% | 28.42% | -1.35% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.07% | 29.53% | -2.46% |
EKG vs. IDNA - Expense Ratio Comparison
EKG has a 0.65% expense ratio, which is higher than IDNA's 0.47% expense ratio.
Dividends
EKG vs. IDNA - Dividend Comparison
EKG has not paid dividends to shareholders, while IDNA's dividend yield for the trailing twelve months is around 1.07%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
EKG First Trust Nasdaq Lux Digital Health Solutions ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.07% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Frequently Asked Questions
EKG and IDNA have a correlation of 0.58, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.18%) compared to EKG (7.09%). In terms of maximum drawdown, EKG dropped -43.82% vs IDNA's -68.26%.
On 3-year performance, IDNA leads with 6.74% vs -0.66% for EKG. On fees, IDNA is cheaper at 0.47% per year. Their volatility is very similar. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IDNA has performed better with a 6.74% return vs -0.66%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IDNA is cheaper with a 0.47% expense ratio, compared with 0.65% for EKG.
IDNA has the higher dividend yield at 1.07%, compared with 0.00% for EKG.
EKG tracks NASDAQ Lux Health Tech Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.65% for EKG and 0.47% for IDNA.
IDNA currently has the higher Sharpe Ratio (1.68 vs -0.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for EKG and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer